Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative disorder marked by the death of dopaminergic neurons in the midbrain, the accumulation of α-synuclein aggregates, and motor deficits. A major contributor to dopaminergic neuronal loss is neuroinflammation. The inflammasome is a multiprotein complex tha...
Main Authors: | Erika d. l. R. M. Cabrera Ranaldi, Karen Nuytemans, Anisley Martinez, Corneliu C. Luca, Robert W. Keane, Juan Pablo de Rivero Vaccari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/6/883 |
Similar Items
-
Extracellular vesicles mediate inflammasome signaling in the brain and heart of Alzheimer’s disease mice
by: Brianna Cyr, et al.
Published: (2024-04-01) -
Inflammasome signaling proteins as biomarkers of COVID-19
by: Roey Hadad, et al.
Published: (2023-04-01) -
Neural–Cardiac Inflammasome Axis after Traumatic Brain Injury
by: Robert W. Keane, et al.
Published: (2023-09-01) -
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
by: Yang Li, et al.
Published: (2023-04-01) -
NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
by: Eleonora Mezzaroma, et al.
Published: (2021-02-01)